8305 NW 27th Street
TissueTech, Inc. is pioneering the field of regenerative medicine through our superior platform technology, cutting edge scientific innovation, and commitment to commercial excellence. The Company markets innovative amniotic and umbilical cord-based products used by physicians around the world in eye care, wound care, and orthopedics. TissueTech’s proprietary technology is clinically proven to promote regenerative healing.
CEO: Amy Tseng
Chief Scientific Officer: Scheffer C.G. Tseng, MD, PhD
CFO: Michael Cornelius
Chief Commercial Officer: Tom Daniells